Table 2.
Meta-analysis between ERCC1 expression and platinum chemosensitivity of NSCLC.
| Items | Subgroup | n | OR | 95% CI | P | I 2 | P for heterogeneity | Analysis model | P for publication bias (Egger) | P for publication bias (Begg) |
|---|---|---|---|---|---|---|---|---|---|---|
| Overall | 14 | 0.53 | 0.30∼0.79 | <0.001 | 53.9 | 0.008 | REM | 0.014 | 0.063 | |
| Ethnicity | Asian | 11 | 0.5 | 0.31∼0.82 | 0.001 | 63.7 | 0.002 | REM | 0.027 | 0.161 |
| Caucasian | 3 | 0.56 | 0.30∼1.07 | 0.088 | 0.0 | 0.839 | FEM | 0.867 | 0.602 | |
| Tumor stage | III-IV | 13 | 0.57 | 0.39∼0.84 | 0.005 | 50.0 | 0.02 | REM | 0.029 | 0.100 |
| Others | 1 | 0.12 | 0.02∼0.59 | 0.009 | NA | NA | NA | NA | NA |